“Superlative transactional IP work, especially in cutting-edge technologies, such as blockchain, medical technology and machine learning“ IAM MAGAZINE 2019
Yuval Horn and Keren Margalit of Horn & Co. represented BioSight Ltd. in its Series B financing round led by Arkin Holdings and US based venture firm Primera Capital
